Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
1.10 CNY
348.03 M CNY
2.44 B CNY
214.86 M
About BETTA PHARMACEUTIC
Sector
Headquarters
Hangzhou
Founded
2003
Website
ISIN
CNE100002DD9
FIGI
BBG006R142J5
Betta Pharmaceuticals Co., Ltd. engages in the research and development, production and sale of anticancer targeted drugs. Its product icotinib hydrochloride tablet, provides treatment for non-small cell lung carcinoma disease. The company was founded on January 7, 2003 and is headquartered in Hangzhou, China.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 300558 is 53.10 CNY — it has increased by 0.55% in the past 24 hours. Watch BETTA PHARMACEUTIC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on SZSE exchange BETTA PHARMACEUTIC stocks are traded under the ticker 300558.
300558 stock has risen by 7.27% compared to the previous week, the month change is a 14.00% rise, over the last year BETTA PHARMACEUTIC has showed a −4.79% decrease.
We've gathered analysts' opinions on BETTA PHARMACEUTIC future price: according to them, 300558 price has a max estimate of 60.00 CNY and a min estimate of 41.40 CNY. Watch 300558 chart and read a more detailed BETTA PHARMACEUTIC stock forecast: see what analysts think of BETTA PHARMACEUTIC and suggest that you do with its stocks.
300558 reached its all-time high on Jul 13, 2020 with the price of 160.66 CNY, and its all-time low was 23.19 CNY and was reached on Nov 7, 2016. View more price dynamics on 300558 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
300558 stock is 7.24% volatile and has beta coefficient of 1.20. Track BETTA PHARMACEUTIC stock price on the chart and check out the list of the most volatile stocks — is BETTA PHARMACEUTIC there?
Today BETTA PHARMACEUTIC has the market capitalization of 22.10 B, it has increased by 8.86% over the last week.
Yes, you can track BETTA PHARMACEUTIC financials in yearly and quarterly reports right on TradingView.
BETTA PHARMACEUTIC is going to release the next earnings report on Apr 23, 2025. Keep track of upcoming events with our Earnings Calendar.
300558 earnings for the last quarter are 0.46 CNY per share, whereas the estimation was 0.22 CNY resulting in a 109.09% surprise. The estimated earnings for the next quarter are 0.44 CNY per share. See more details about BETTA PHARMACEUTIC earnings.
BETTA PHARMACEUTIC revenue for the last quarter amounts to 843.94 M CNY, despite the estimated figure of 758.52 M CNY. In the next quarter, revenue is expected to reach 818.44 M CNY.
300558 net income for the last quarter is 192.28 M CNY, while the quarter before that showed 125.81 M CNY of net income which accounts for 52.84% change. Track more BETTA PHARMACEUTIC financial stats to get the full picture.
Yes, 300558 dividends are paid annually. The last dividend per share was 0.17 CNY. As of today, Dividend Yield (TTM)% is 0.32%. Tracking BETTA PHARMACEUTIC dividends might help you take more informed decisions.
BETTA PHARMACEUTIC dividend yield was 0.33% in 2023, and payout ratio reached 20.44%. The year before the numbers were 0.14% and 20.00% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Nov 21, 2024, the company has 1.94 K employees. See our rating of the largest employees — is BETTA PHARMACEUTIC on this list?
Like other stocks, 300558 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade BETTA PHARMACEUTIC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So BETTA PHARMACEUTIC technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating BETTA PHARMACEUTIC stock shows the buy signal. See more of BETTA PHARMACEUTIC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.